Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 1782-1789

  Murali, Rajmohan ^a,b,c   Haydu, Lauren E ^b,c   Long, Georgina V ^b,c   Quinn, Michael J ^b,c   Saw, Robyn P M ^b,c   Shannon, Kerwin ^b,c   Spillane, Andrew J ^b,c   Stretch, Jonathan R ^b,c   Kefford, Richard F ^b,c,d   Thompson, John F ^b,c   Scolyer, Richard A ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIMARY CUTANEOUS MELANOMA; ULCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; METASTASECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84865107423     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2265-y     Document Type: Article

References (19)

1. Reintgen C, Shivers S, Reintgen M, et al. The changing face of malignant melanoma. J Surg Oncol. 2010;101:443-6.
2. McKinnon JG, Yu XQ, McCarthy WH, et al. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer. 2003;98:1223-31. (Pubitemid 37099907)
3. Gimotty PA, Guerry D, Ming ME, et al. Thin primary cutaneous malignant melanoma: a prognostic tree for 10-year metastasis is more accurate than American Joint Committee on Cancer staging. J Clin Oncol. 2004;22:3668-76. (Pubitemid 41095205)
4. Kalady MF, White RR, Johnson JL, et al. Thin melanomas: predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003;238:528-35.
5. Mansson-Brahme E, Carstensen J, Erhardt K, et al. Prognostic factors in thin cutaneous malignant melanoma. Cancer. 1994;73: 2324-32. (Pubitemid 24129115)
6. Leiter U, Buettner PG, Eigentler TK, et al. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol. 2004;22:3660-7. (Pubitemid 41095204)
7. Slingluff CL Jr, Seigler HF. Thin malignant melanoma: risk factors and clinical management. Ann Plast Surg. 1992;28:89-94.
8. Slingluff CL, Jr., Vollmer RT, Reintgen DS, et al. Lethal ''thin'' malignant melanoma. Identifying patients at risk. Ann Surg. 1988;208:150-61.
9. Guitart J, Lowe L, Piepkorn M, et al. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol. 2002;138:603-8.
10. Finley JW, Gibbs JF, Rodriguez LM, et al. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system. Am Surg. 2000; 66:527-31.
11. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the management of melanoma in Australia and New Zealand. Wellington: The Cancer Council Australia and Australian Cancer Network, Sydney and New Zealand Guidelines Group; 2008.
12. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199-206.
13. Murali R, Hughes MT, Fitzgerald P, et al. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly Clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg. 2009;249:641-7.
14. Scolyer RA, Shaw HM, Thompson JF, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am J Surg Pathol. 2003;27:1571-6. (Pubitemid 37486620)
15. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17, 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-34. (Pubitemid 32786275)
16. Azzola MF, Shaw HM, Thompson JF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer. 2003;97:1488-98. (Pubitemid 36297779)
17. Francken AB, Shaw HM, Thompson JF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol. 2004;11:426-33. (Pubitemid 40486754)
18. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol. 1996;14:1218-23. (Pubitemid 26105529)
19. Lock-Andersen J, Hou-Jensen K, Hansen JP, et al. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg. 1995;29:141-8.